Package 51672-4185-5

{"route": ["ORAL"], "spl_id": "0c6d8e37-6982-22d4-e063-6294a90a4f6b", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["X72RBB02N8"], "rxcui": ["198358", "198359"], "spl_set_id": ["f2edb3ed-da20-4093-88ea-00fe781e47e0"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51672-4185-1)", "package_ndc": "51672-4185-1", "marketing_start_date": "20170420"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (51672-4185-5)", "package_ndc": "51672-4185-5", "marketing_start_date": "20231215"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (51672-4185-6)", "package_ndc": "51672-4185-6", "marketing_start_date": "20170420"}], "brand_name": "Felbamate", "product_id": "51672-4185_0c6d8e37-6982-22d4-e063-6294a90a4f6b", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4185", "generic_name": "Felbamate", "labeler_name": "Taro Pharmaceuticals U.S.A., inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Felbamate", "active_ingredients": [{"name": "FELBAMATE", "strength": "400 mg/1"}], "application_number": "ANDA207093", "marketing_category": "ANDA", "marketing_start_date": "20170420", "listing_expiration_date": "20261231"}